Stress-testing: still worth the stress?
Stress tests are only as valuable as regulators’ ability to predict future shocks accurately
The surge of supervisory stress-testing that began after the financial crisis had a clear purpose: to identify banks in danger of imminent distress and reassure the market that those still standing were solvent and could survive the downturn.
More than a decade later, issuance costs for bank debt could hardly be lower, even for subordinated bonds. That suggests a level of confidence among investors that they understand the risks in the banking sector. And yet, bankers say the data demands from regulatory stress-testing are, if anything, becoming more intense.
That has prompted the European Banking Authority to consider a review of its biennial stress-test process before it is run in 2022, with a particular focus on the “usefulness” of the entire undertaking.
Currently, European supervisors feed the results into their Pillar 2 capital add-ons regime. But there is precious little disclosure of how far this affects capital requirements and how the add-on is broken down: for instance, the contribution of data and governance difficulties revealed during the test versus actual solvency risks uncovered by the results.
“The effects of the test are very far from the attention of the front office,” one banker told Risk.net recently, which doesn’t sound like the Pillar 2 capital impact really moves the dial.
The Bank of England has gone one stage further, deploying the overall results across the sector as an input for the countercyclical capital buffer applied to all banks. The greater the loss, the higher the buffer. The US Federal Reserve has mooted going further still, by incorporating the test into the individual Pillar 1 capital requirements of each bank in place of the existing fixed 2.5% capital conservation buffer.
There is sympathy for the BoE’s method of deploying the results as a macro indicator of risk. But US banks have been far more critical of the Fed’s so-called stress capital buffer, arguing it duplicates existing risk-based capital requirements such as the Basel framework and the buffers for global systemically important banks.
No better than Basel?
There’s certainly a case for seeing the stress test as a cruder version of Basel risk weightings. The Basel internal model methodologies require banks to calculate capital based on the probability of a range of loss outcomes. A stress test focuses on the impact of a single – or perhaps a few – specific scenarios chosen by the supervisor. Hence the outputs are only as valuable as the regulator’s ability to predict the most appropriate stress scenario.
US lobbyists have argued for an average of impacts over multiple scenarios, and the EBA review will consider adding extra scenarios to the existing single-shock approach.
But would this make the tests any more useful for the banks themselves? The largest, most sophisticated firms already run tests internally, sometimes daily. Alas, the data requirements from supervisors for annual testing rarely match up with internal risk management.
Increasingly, regulators seem to see the stress-test exercise more as a way to identify process failures rather than balance sheet risks. And banks see them as a capital constraint that is misaligned with the Basel risk-based ratios, or even just as an extra layer of bureaucracy. The annual round of regulatory stress-test results is in danger of becoming an expensive circus that doesn’t specifically reduce risk in the system – especially if, as Risk.net uncovered recently, banks are gaming the results.
If the concern is that banks are modelling and assessing risk incorrectly, then perhaps a more valuable use of supervisors’ limited time and resources would be to deploy their challenger models directly to the Basel framework. The Fed already does this for stress-test outputs. Regulators can then step up scrutiny of those banks with model outputs that deviate a long way from the challenger, rather than imposing a stress test for all risks on all banks.
Some of this analysis of model risk is already built into the Basel framework. Regulators took a long time to agree on how to validate internal models under the Fundamental Review of the Trading Book. Ensuring rigorous internal model validation might do more to identify any risks the banks are missing than a few weeks of quality assurance each year during the stress test.
コンテンツを印刷またはコピーできるのは、有料の購読契約を結んでいるユーザー、または法人購読契約の一員であるユーザーのみです。
これらのオプションやその他の購読特典を利用するには、info@risk.net にお問い合わせいただくか、こちらの購読オプションをご覧ください: http://subscriptions.risk.net/subscribe
現在、このコンテンツを印刷することはできません。詳しくはinfo@risk.netまでお問い合わせください。
現在、このコンテンツをコピーすることはできません。詳しくはinfo@risk.netまでお問い合わせください。
Copyright インフォプロ・デジタル・リミテッド.無断複写・転載を禁じます。
当社の利用規約、https://www.infopro-digital.com/terms-and-conditions/subscriptions/(ポイント2.4)に記載されているように、印刷は1部のみです。
追加の権利を購入したい場合は、info@risk.netまで電子メールでご連絡ください。
Copyright インフォプロ・デジタル・リミテッド.無断複写・転載を禁じます。
このコンテンツは、当社の記事ツールを使用して共有することができます。当社の利用規約、https://www.infopro-digital.com/terms-and-conditions/subscriptions/(第2.4項)に概説されているように、認定ユーザーは、個人的な使用のために資料のコピーを1部のみ作成することができます。また、2.5項の制限にも従わなければなりません。
追加権利の購入をご希望の場合は、info@risk.netまで電子メールでご連絡ください。
詳細はこちら 我々の見解
SpaceXがCMEの個別銘柄先物に待望の追い風をもたらした
S&P 500先物契約へのIPO関連の追加契約として、新たな契約が急増する可能性があります
Bank vs non-bank: FX’s two-tier reality
CME and LSEG data show banks provide sticky and broad liquidity, while non-banks cling tightly to the price
規制当局はエンフォースメントを甘くしているのか?(そして、私たちはそれを気にするべきなのか?)
米国の規制当局は、技術的な規則違反に対する罰則を緩和しており、小さくとも重要なリスクが見過ごされてしまうのではないかという懸念が高まっています
FX HedgePoolを超えて:オール・トゥ・オール(All-to-All)の今後はどうなる?
この取引モデルの支持者たちは、その将来性を明るく見ていますが、普及に向けた障壁は依然として残っています。
バーゼル協定のCVA見直し:米国では説得力があるものの、欧州ではそれほどではない
信用リスクモデルの使用禁止は、米国の銀行がより高度なCVA手法を採用するきっかけとなる可能性があります
オルタナティブ・データは予測市場に賭けているのか?
新たなデータの豊富な情報源を提供する一方で、法的な不確実性は依然として残っています
「SaaSpocalypse」は、プライベート市場にリスクモデルが必要であることを示している
投資家たちは、プライベート・クレジットにおける損失がどれほど深刻なものになるか、ほとんど見当がつかない
プライベート・クレジットの開示は、答えよりも疑問を残す結果となっている
指標の不統一や手当たり次第の報告が、米国の金融機関間の比較を妨げています